COVID-19 U07.1
Conditions
Interventions
Group 1: Observation group:
All patients with a focal-neurological deficit and positive SARS-CoV-2 PCR who are in the Freiburg University Hospital for Treatment or are presented on an outpatient basis
Sponsors
Klinik für Neurologie und Neurophysiologie Universitätsklinikum Freiburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age > 18 Years Proof of SARS-CoV-2 Infection Anamnestic Anosmia/Ageusia Clinical or radiological indication of encephalitis in COVID-19 disease
Exclusion criteria
Exclusion criteria: Lack of possibility for oral and written patient information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Predictive value of the clinical symptoms ageusia and anosmia for a negative outcome of COVID-19 disease and for the detection of changes in the brain, meninges and cerebrospinal fluid in the instrumental diagnostics. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Correlation between the results of different diagnostic procedures and the clinical course • Correlation between the results of various diagnostic procedures and vital parameters and, if applicable, ventilation parameters and clinical findings • Death from COVID-19 disease • Further research questions are derived in the course of the project | — |
Countries
Germany
Contacts
Public ContactJonas Hosp
Klinik für Neurologie Universitätsklinikum Freiburg
Outcome results
None listed